vs
Side-by-side financial comparison of INTRUSION INC (INTZ) and PLUS THERAPEUTICS, INC. (PSTV). Click either name above to swap in a different company.
INTRUSION INC is the larger business by last-quarter revenue ($1.5M vs $1.4M, roughly 1.1× PLUS THERAPEUTICS, INC.). INTRUSION INC runs the higher net margin — -190.7% vs -417.9%, a 227.2% gap on every dollar of revenue. On growth, PLUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (-3.2% vs -11.6%). INTRUSION INC produced more free cash flow last quarter ($-549.0K vs $-6.3M). Over the past eight quarters, INTRUSION INC's revenue compounded faster (14.4% CAGR vs -9.7%).
INTRUSION INCINTZEarnings & Financial Report
Intrusion Inc. is a cybersecurity company based in Plano, Texas. It provides cybersecurity solutions, including network intrusion detection and prevention systems.
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecu...
INTZ vs PSTV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5M | $1.4M |
| Net Profit | $-2.8M | $-5.7M |
| Gross Margin | 74.3% | — |
| Operating Margin | -192.4% | -420.0% |
| Net Margin | -190.7% | -417.9% |
| Revenue YoY | -11.6% | -3.2% |
| Net Profit YoY | -44.4% | -46.4% |
| EPS (diluted) | $-0.15 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5M | $1.4M | ||
| Q3 25 | $2.0M | $1.4M | ||
| Q2 25 | $1.9M | $1.4M | ||
| Q1 25 | $1.8M | $1.1M | ||
| Q4 24 | $1.7M | $1.4M | ||
| Q3 24 | $1.5M | $1.5M | ||
| Q2 24 | $1.5M | $1.3M | ||
| Q1 24 | $1.1M | $1.7M |
| Q4 25 | $-2.8M | $-5.7M | ||
| Q3 25 | $-2.1M | $-4.4M | ||
| Q2 25 | $-2.0M | $5.2M | ||
| Q1 25 | $-2.1M | $-17.4M | ||
| Q4 24 | $-2.0M | $-3.9M | ||
| Q3 24 | $-2.0M | $-2.9M | ||
| Q2 24 | $-2.1M | $-2.9M | ||
| Q1 24 | $-1.7M | $-3.3M |
| Q4 25 | 74.3% | — | ||
| Q3 25 | 76.6% | — | ||
| Q2 25 | 76.4% | — | ||
| Q1 25 | 75.7% | — | ||
| Q4 24 | 74.9% | — | ||
| Q3 24 | 77.1% | — | ||
| Q2 24 | 76.0% | — | ||
| Q1 24 | 80.0% | — |
| Q4 25 | -192.4% | -420.0% | ||
| Q3 25 | -108.6% | -320.8% | ||
| Q2 25 | -111.4% | -110.6% | ||
| Q1 25 | -117.9% | -333.9% | ||
| Q4 24 | -113.5% | -276.2% | ||
| Q3 24 | -135.5% | -260.9% | ||
| Q2 24 | -139.2% | -289.1% | ||
| Q1 24 | -218.6% | -196.7% |
| Q4 25 | -190.7% | -417.9% | ||
| Q3 25 | -106.5% | -316.6% | ||
| Q2 25 | -109.0% | 370.6% | ||
| Q1 25 | -118.2% | -1643.2% | ||
| Q4 24 | -116.8% | -276.4% | ||
| Q3 24 | -136.3% | -197.4% | ||
| Q2 24 | -141.6% | -229.9% | ||
| Q1 24 | -151.7% | -194.5% |
| Q4 25 | $-0.15 | $0.95 | ||
| Q3 25 | $-0.10 | $-0.04 | ||
| Q2 25 | $-0.10 | $-0.01 | ||
| Q1 25 | $-0.11 | $-1.19 | ||
| Q4 24 | $0.19 | $-0.51 | ||
| Q3 24 | $-0.35 | $-0.37 | ||
| Q2 24 | $-0.53 | $-0.71 | ||
| Q1 24 | $-0.94 | $-0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $8.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.3M | $4.0M |
| Total Assets | $10.4M | $16.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.6M | $8.6M | ||
| Q3 25 | $4.5M | $16.6M | ||
| Q2 25 | $8.4M | $6.9M | ||
| Q1 25 | $10.7M | $9.9M | ||
| Q4 24 | $4.9M | $3.6M | ||
| Q3 24 | $1.1M | $4.8M | ||
| Q2 24 | $1.5M | $8.4M | ||
| Q1 24 | $122.0K | $3.2M |
| Q4 25 | $7.3M | $4.0M | ||
| Q3 25 | $9.8M | $5.1M | ||
| Q2 25 | $11.6M | $3.0M | ||
| Q1 25 | $13.4M | $-23.6M | ||
| Q4 24 | $6.3M | $-8.9M | ||
| Q3 24 | $2.6M | $-5.2M | ||
| Q2 24 | $2.9M | $-7.6M | ||
| Q1 24 | $-1.2M | $-4.8M |
| Q4 25 | $10.4M | $16.3M | ||
| Q3 25 | $13.7M | $18.7M | ||
| Q2 25 | $16.4M | $10.3M | ||
| Q1 25 | $18.0M | $12.1M | ||
| Q4 24 | $11.5M | $6.6M | ||
| Q3 24 | $7.4M | $7.0M | ||
| Q2 24 | $7.5M | $11.2M | ||
| Q1 24 | $5.7M | $5.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-531.0K | $-6.3M |
| Free Cash FlowOCF − Capex | $-549.0K | $-6.3M |
| FCF MarginFCF / Revenue | -37.1% | -459.9% |
| Capex IntensityCapex / Revenue | 1.2% | 2.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-7.5M | $-20.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-531.0K | $-6.3M | ||
| Q3 25 | $-3.0M | $-2.5M | ||
| Q2 25 | $-1.6M | $-5.8M | ||
| Q1 25 | $-1.7M | $-6.2M | ||
| Q4 24 | $-178.0K | $-1.2M | ||
| Q3 24 | $-2.1M | $-3.7M | ||
| Q2 24 | $-2.9M | $-1.1M | ||
| Q1 24 | $-1.1M | $-4.5M |
| Q4 25 | $-549.0K | $-6.3M | ||
| Q3 25 | $-3.0M | $-2.6M | ||
| Q2 25 | $-1.9M | $-5.8M | ||
| Q1 25 | $-2.1M | $-6.2M | ||
| Q4 24 | $-645.0K | $-1.2M | ||
| Q3 24 | $-2.1M | $-3.7M | ||
| Q2 24 | $-3.0M | $-1.2M | ||
| Q1 24 | $-1.2M | $-4.6M |
| Q4 25 | -37.1% | -459.9% | ||
| Q3 25 | -153.2% | -184.3% | ||
| Q2 25 | -101.1% | -417.6% | ||
| Q1 25 | -117.3% | -583.1% | ||
| Q4 24 | -38.5% | -86.5% | ||
| Q3 24 | -140.4% | -253.7% | ||
| Q2 24 | -202.3% | -96.2% | ||
| Q1 24 | -104.2% | -271.5% |
| Q4 25 | 1.2% | 2.2% | ||
| Q3 25 | 1.7% | 1.9% | ||
| Q2 25 | 17.8% | 0.5% | ||
| Q1 25 | 22.1% | 0.3% | ||
| Q4 24 | 27.9% | 0.8% | ||
| Q3 24 | 2.2% | 1.0% | ||
| Q2 24 | 2.1% | 6.3% | ||
| Q1 24 | 5.7% | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.13× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
